Document is current
Any future updates will be listed below
-
Authors
Au, Yan Zi
Gu, Muxin
De Braekeleer, Etienne
Gozdecka, Malgorzata
Aspris, Demetrios
Tarumoto, Yusuke https://orcid.org/0000-0001-6652-9618
Cooper, Jonathan
Yu, Jason https://orcid.org/0000-0001-5203-3603
Ong, Swee Hoe https://orcid.org/0000-0002-3629-5387
Chen, Xi
Tzelepis, Konstantinos https://orcid.org/0000-0002-4865-7648
Huntly, Brian J. P. https://orcid.org/0000-0003-0312-161X
Vassiliou, George https://orcid.org/0000-0003-4337-8022
Yusa, Kosuke https://orcid.org/0000-0002-3442-021X
-
Funding
Funding for this research was provided by:
Kay Kendall Leukaemia Fund (KKL920)
Kay Kendall Leukaemia Fund (KKL920)
Kay Kendall Leukaemia Fund (KKL920)
Takeda Science Foundation
Wellcome Trust (WT206194)
Wellcome Trust (WT206194)
Wellcome Trust (WT206194)
Wellcome Trust (WT206194)
Wellcome Trust (WT206194)
Wellcome Trust (WT206194)
Wellcome Trust (WT206194)
Wellcome Trust (RG94424)
Cancer Research UK (C22324/A23015)
Bloodwise (17006)
- License Information
-
More Information
Article History
Received: 6 August 2019
Revised: 15 July 2020
Accepted: 22 July 2020
First Online: 6 August 2020
Compliance with ethical standards
:
: GSV is a consultant for Kymab and Oxstem. All the remaining authors declare no conflict of interest.
